News & Media
ODPHP plays a crucial role in keeping the nation healthy. Stay up to date on our work by checking out our news and announcements, upcoming events, and expert insights in the Prevention Policy Matters Blog.
Upcoming Public Workshop on Reducing the Risk of Preventable Adverse Drug Events Associated with Hypoglycemia in the Older Population
The Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, Professional Affairs and Stakeholder Engagement Staff, is hosting a one day public workshop entitled “Reducing the Risk of Preventable Adverse Drug Events Associated with Hypoglycemia in the Older Population.” During the workshop, public and federal partners will discuss:The importance of individualizing glycemic control targets for older patients with diabetes Risk reduction for serious hypoglycemia Medication safety efforts, both those that are a part of FDA’s Safe Use Initiative and those external to the FDA, that are relevant and important to older adults living with diabetes Future areas of research
The National Action Plan for Adverse Drug Event Prevention identifies hypoglycemia as a common, clinically significant, and preventable adverse effect from diabetes agents that can cause serious harm to patients.…